Printable Version
The Office of Research at Duke-NUS Graduate Medical School has enjoyed exponential growth since the recruitment of the first faculty member in September 2005. The number of regular rank faculty has grown to 73, with about half of these full-time, and most of the faculty arrived in 2008 and 2009. “Our research programs are really just beginning to take off – that growth will continue for another couple of years,” said
Professor Patrick Casey, Senior Vice-Dean of Research at Duke-NUS.

You could hardly find two cities so different and so far apart – Durham and Singapore. One, a civil war heritage city set in the beautiful state of North Carolina in America’s east, the other, a historic Southeast Asian trading center and now an impressively modern city at the tip of the Malay Peninsula. Yet, for Duke Faculty and students, the two places have been closely tied ever since the opening of the Duke-NUS Graduate Medical School Singapore in 2007. Every year since then, a handful of adventurous American students from Duke and intrepid Singaporean students from Duke-NUS have taken up opportunities to pursue their third year of research a world away, in the other locale.

The value and importance of ongoing cutting edge research being conducted by three top cancer scientists at Duke-NUS Graduate Medical School have been recognized by independent government funding agencies in Singapore.

As a member of the Duke-NUS Project KAREn team, I was fortunate to have the opportunity to spend time in the Karen hill tribe village of Hoay Khao Lip (HKL) near Chiangmai in northern Thailand in January and May 2010. This project was the first student-initiated community service project.
Strength, Courage and Compassion at Sentosa

Editor: Greg Lee
Production and copy-editing: Adeline Sim
Vital Science is a quarterly publication produced by the Office of Communications and Development.

For this issue, the banner features a confocal microscopy image depicting cancer cells with autophagosome and lysosome vesicles (Image provided by Assistant Professor Mei Wang, Laboratory of Cancer Molecular Pharmacology).